Cancer is the most common cause of death in Thailand, with the mortality almost doubled during 1998-2011 (from 48.4 to 95.2 per 100 000). The estimated number of new cancer cases in 2011 was 112 392. Our review provides baseline data on the current epidemiological situation with head and neck (HN) cancer in Thailand based on reports of the National Cancer Registry and findings from local and international publications. Collectively, HN cancer approaches agestandardized rate (ASR) incidence of 15.7 and 10.7 per 100 000 males and females, respectively, and is ranked among the top five dominant cancers in Thailand. The leading HN malignancies in men are oral (ASR incidence 4.6 per 100 000), nasopharyngeal (ASR 2.8) and laryngeal (ASR 2.7) cancers, while the most common cancers in women are thyroid (ASR 5.1) and oral (ASR 3.2) carcinomas. Some local habits (betel quid chewing, traditional cigarette smoking and alcohol intake) are associated with the high incidence of oral cancer in Northeast Thailand. Despite important prognostic significance, the role of human papillomavirus infection in various HN cancers from Thailand has been scarcely addressed. There is a growing incidence of thyroid cancer over the last two decades. The Thai population overall, compared to worldwide rates of HN malignancies, has a lower incidence of laryngeal and thyroid cancers but higher incidence of nasopharyngeal cancer.
INTRODUCTION
Thailand is a country in Southeast Asia, which is located at the center of the Greater Mekong Subregion. The country is populated by almost 66 million people ranking it among the top 20 most populated countries in the world. 1 There are 76 provinces arranged in four geographical regions, including Northern, Northeastern, Central and Southern Thailand. Rapid socioeconomic development of the country in the last decades and effective control of communicable diseases resulted in the emergence of cancer as the leading cause of death in Thailand. 2 The most recent estimates indicate that cancer was the most common cause of death in Thailand in 2011, with the mortality almost doubled since 1998 (from 48.4 to 95.2 per 100 000). 3 The population-based cancer registry is a vital tool for public health needs, being the core of any cancer control program. There are 16 province-and region-based cancer registries in Thailand responsible for cancer statistics, which covers about 33.1% of total population. 4 Every 5 years, the Ministry of Public Health and the Ministry of Education release a special volume "Cancer in Thailand," which contains available data on incidence and distribution of different malignancies. The latest edition was published in 2015, and it provided cancer statistics that were collected from 2010 to 2012. 4 The estimated number of new cancer cases in Thailand increased with population growth. 4, 5 There were 54 586 male and 57 806 female cancers recorded in 2011, which corresponded to age-standardized rates (ASRs) of 143.3 and 131.9 per 100 000 population, respectively.
The leading cancer site is liver and biliary tree in men, and breast in Head and neck (HN) cancer is one of the most common cancers worldwide. 6 Epidemiology of HN cancer often remains partially hidden, because many reports present the data according to specific sites of cancer instead of the HN cancer as a group. There is a significant variability in the definition of HN cancer. Basically, cancers of the HN are considered to include the upper aerodigestive tract, that is all lesions of the mucosal surfaces from nasal cavity, oral cavity, nasopharynx down to larynx, hypopharynx and trachea, with routinely added major salivary glands, and more rarely included thyroid and parathyroid. 7 We considered the thyroid gland as one of the major representatives of HN malignancy due to the immense role of HN specialists in the management of thyroid cancer patients. Epidemiology of HN cancer in Thailand is scarcely addressed in the literature. 8 Most of the publications are based on data from hospital registries, which could not provide an inclusive depiction of HN cancer on a nationwide level F I G U R E 1 Leading cancers in Thailand, mean annual ASR 2010-2012 (per 100 000 population). Collective incidence of all head and neck cancers shown in white bars. Oral cavity cancer is combined with salivary gland malignancies. NHL = non-Hodgkin lymphoma due to considerable variations of some HN cancer entities among the provinces. Local cancer statistics are made available from the national database; however, access for the international medical and scientific community is limited.
Here, we present an overview of the current epidemiological profile of HN cancer in Thailand based on the report from the populationbased cancer registries with additional support by findings from available local and international publications.
METHODOLOGY
The first population-based cancer registry started in 1986 in Chiang Mai province, and currently the whole network is expanded to the 16 most populated provinces and regions of the Kingdom. The populationbased cancer registries in Thailand carried out the data by standard procedure according to the International Association for Research on Cancer (IARC). The data on cancer cases were collected from all hospitals, laboratories and death certificates, mainly by active data collection. 4 All registered cases were followed up by both passive procedures with death certificate matching and active procedures with scrutiny of hospital records, postal enquiries and through the network of health care system. Quality control was assured through percentage of morphologically verified cases and percentage of death certificate only cases. The population denominators used for the calculation of incidence rates were taken from the Population Projections report for Thailand 2010-2040 by the Population Projection Working Group, Office of the National Economic and Social Development Board. 4 It should be noted that at the current stage, a database of the National Cancer Registry has several limitations. These include variability of the participating regions across the years, which makes difficult to estimate time trends, and absence of data on mortality and survival. However, continuing evolution and improvement of the cancer registry over the last 40 years is aimed to achieve homogenous standards across the country.
The age-specific incidence rate was calculated by dividing the number of cancer cases in each 5 years age and sex structure of population in the age group by estimated population as a person-year, and then multiplied by 100 000 (expressed per 100 000 population). The age-standardized incidence rate was calculated by estimating the agespecific incidence rates and applying these rates to the standard population (per 100 000). The data from the "Cancer in Thailand, 2010-2012" were utilized in the analysis and presentation. 4 The HN cancer in this review is defined as the cancer sites of the International Classification of Diseases for Oncology (ICD-O) codes C00-C14, C30-C32 and C73, which are oral cavity, major salivary glands, oropharynx, nasopharynx, hypopharynx, nasal cavity, paranasal sinuses, larynx, trachea and thyroid. 9 Since the population-based registry mainly uses extent of cancer instead of stage in the report, we describe the staging in a term of extent, that is local, regional and distant.
PubMed, Scopus and Google Scholar were queried for a combination of keywords "Thailand" and "head-neck cancer/carcinoma," including single site entities (e.g. oropharyngeal/oropharynx, thyroid, etc.)
Additional search was performed for the same cancer locations coupled with Thailand as a country of affiliation of the authors. All available publications released since 1990 were reviewed to obtain additional information on epidemiologically relevant data, such as risk factors, cancer incidence, survival and more.
HEAD AND NECK CANCER IN THAILAND
There were 10 707 new cases of HN cancer (men -56.6% and women -43.4%) recorded in Thailand in 2011. 4 Collectively, HN cancer approaches ASR incidence of 15.7 and 10.7 per 100 000 males and females, respectively (Figure 1 ). The leading HN malignancies in men are oral, nasopharyngeal and laryngeal cancers, while the most common cancers in women are thyroid and oral carcinomas (Table 1) . Compared to the previous decade, there was a rise of HN cancer, in contrast with the overall slight decrease of cancer incidence in Thailand. 4, 5 This TA B L E 1 ASR incidence of major head and neck malignancies in Thailand, 2011 (per 100 000 population) 8 Recent studies reported that in addition to the growing incidence, survival rates of HN in Thailand are not improving. 10 An issue of urgent need to recruit sufficient numbers of specialists involved in the treatment of HN cancer, especially HN surgeons and radiotherapists, has been addressed at the national level. 8 
Oral cavity cancer
Out of 3293 new cases of oral cancer in 2011, 54.4% were diagnosed in men and 45.6% in women, which correspond with ASR incidence of 4.6 and 3.2 per 100 000 male and female population, respectively (Table   1) . 4 Oral cancer is one of the most common malignancies in Thai men, ranked seventh by incidence. Tongue and mouth are the main locations (Table 1 ). The incidence increases sharply from 65 years of age in both genders. Among the HN cancers, cancer of the oral cavity caused the highest number of out-patient visits (28.2%) and in-patient admissions (25%) in 2011. 8 The most common extent of disease at presentation is regional followed by the local stage. 4 Squamous cell carcinoma, usually well or moderately differentiated, accounts for more than 95% of all cases. 11 The cancer of oral cavity was ranked as the sixth most common malignancy in Thai females in 1990, but it had been dropped out from the top 10 cancers list by 2011. At the same time, oral cancer is consistently placed among 6-8 most common malignancies in male population for the last 40 years. 2,4,5 A male-to-female ratio of oral cancer in
Thailand is within 1.1-1.2 range, which is different from the worldwide and Asian estimates (usually 1.9-2.0). 2, 4, 12 This remarkable finding is largely contributed by the high incidence of oral cancer in women from the Northeast region, with sex ratio 0.5-0.7. 4 Studies from Khon Kaen, a Northeastern province in Thailand, linked this female preponderance with local habits of betel quid chewing, traditional cigarette smoking and alcohol drinking, [13] [14] [15] with betel quid chewing being the strongest risk factor for oral cancer. 13, 16 Oral human papillomavirus (HPV) infection is the putative precursor to HPV-related HN cancer, which is the best illustrated by oropharyngeal carcinoma (see below). Association with oral cancer is not so strong. 6, 17 Several local studies addressed the prevalence of HPV in oral squamous cell carcinoma, and found HPV rate 3-30%, depending on the technique employed. [18] [19] [20] Mouth cancer: Major locations of this multisite entity were floor of mouth and buccal mucosa. 11 ASR incidence was 2.2 and 1.5 per 100 000 of Thai men and women, respectively. 4 The peak incidence in 2011 was in the age group of 50-55 years old, which had been shifted from 45 to 50 years in 2002. 4, 5 Lip cancer: The incidence of lip carcinoma was lower than that of mouth and tongue malignancies, with ASR incidence of 0.2 and 0.7 per 100 000 in men and women, respectively. 4 Out of 414 new cases diagnosed in 2011, the vast majority (82.2%) were in females. 4 Lip cancer is a main entity contributing to the described above low sex ratio of oral cancer in Thailand. Lip cancer had the best survival rate (with 5-year survival greater than 70%) among all oral cancer sites based on the study from endemic province in the Northeast Thailand. 15 Recently, the changing pattern of the oral cancer subsites has been reported, for example growth of tongue cancer and declining of carcinoma of the buccal mucosa during the last 30 years. 10 The latter was likely associated with a cessation of betel quid chewing in certain regions, while continuing habits of smoking and alcohol drinking could contribute to tongue cancer rates.
Oral cancer incidence in Thailand is different from worldwide projections (5.5 in men and 2.5 in women, per 100 000 population), having lower rates in males and higher rates in females. 12 Estimates from GLOBOCAN 2012 suggested that cancer of oral cavity had the highest ASR mortality (2.6 and 1.6 per 100 000 males and females, respectively) among all HN malignancies in Thailand. 12 A study from the South Thailand found that 5-year overall survival for the oral cancer was 25.9%. 21 Usually, tongue cancer has the worst and lip cancer has the best relative survival rates. 15 According to the region-based studies, early diagnosis was improved during the last decades, but no significant gain in survival for oral cancer patients was achieved. 10 
Oropharyngeal cancer
The ASR incidence of oropharyngeal cancer in Thailand in 2011 was 1.4 per 100 000 in men and 0.4 per 100 000 in women (Table 1) , slightly higher than a decade ago (1.1 and 0.2 for males and females, respectively). 4, 5 The incidence is growing from age 45 years and approaches peak level in the over 75 age group. The main anatomical location is the tonsil. Most patients are diagnosed with advanced stage. 15, 21 HPV, particularly high-risk types 16 and 18, is the major infectious cause of oropharyngeal cancer, especially of tonsil and tongue base primaries. 22, 23 The proportion of HPV-associated oropharyngeal cancers is currently growing in the Western world, with prevalence estimates in the United States approaching 80%. 6 As a result, the ratio of oropharyngeal cancer to other HN cancers is around 30% in Western practice, which is substantially different from Asian population (12%) and Thailand (< 10%). 4, 24 Meta-analysis studies suggest that HPV prevalence in oropharyngeal cancer is low in the Asia Pacific region. 25 To date, there is only anecdotal evidence of low HPV rate (17%) in oropharyngeal cancer from Thailand. 19 Reliable and accurate data are crucial to inform local public health policies and to render treatment decisions, because HPV-associated HN cancers tend to have favorable prognosis, permitting less aggressive treatment. 6 Tobacco smoking and alcohol use play the main role in development of HPV-negative cancer of oropharynx, often acting synergistically. 6 One study from the Northern Thailand found that significant decrease in the oropharyngeal cancer incidence during 1988-1999 was linked to the changing behavior of betel quid chewing in the region. 26 This considers that local habits (betel chewing and traditional cigar smoking) may play etiological role in some cases of oropharyngeal cancer, especially in rural areas of Thailand.
Nasopharyngeal cancer
Almost 1500 new cases of nasopharyngeal carcinoma were diagnosed across the country in 2011. 4 Most of the patients (63%) were males.
The peak incidence was in the age range of 55-70 years in both genders. The most common extent of disease at diagnosis was "regional";
however, these data are not consistent among provinces since many of the local registries did not provide information on staging. 4 The most common histological types of nasopharyngeal cancer are undifferentiated and squamous cell nonkeratinizing carcinoma. 11 In male population, ASR incidence dropped from 3.4 (per 100 000) in 1996 to 3.1 in 2002 and further to 2.8 in 2011.
Nasopharyngeal cancer is endemic in Southeast Asia (mainly Southern China) due to the local diet saturated with salty preserved fish and also genetic traits. 27 GLOBOCAN database estimates ASR incidence (per 100 000 population) of nasopharyngeal carcinoma in Southeast Asia as 6.4 in males and 2.4 in females, much higher than worldwide incidence -1.7 in men and 0.7 in women. 12 The rate in Thailand is higher than worldwide incidence; however, it is significantly lower than in neighboring endemic Southeast Asia, owing to the different diet styles. 28 In the same fashion, mortality rate of nasopharyngeal carcinoma in Thailand (1.3 per 100 000 population) is in between the worldwide mortality (0.7) and the Southeast Asian (2.5) mortality. 12 Epstein-Barr virus (EBV) plays a crucial role in carcinogenesis, diagnosis and prognosis of nasopharyngeal cancer, also having clinical use in posttreatment surveillance. 29 There are small-series studies from
Thailand, which confirm EBV etiology of nasopharyngeal carcinoma in local population. 30, 31 Additional studies focused on noninfectious causes found that tobacco smoking is another important risk factor. 32 The case-control study in the northeast of Thailand found that consumption of sea-salted fish at least once a week was a significant risk factor, as well as working in agriculture or as a woodcutter. 33 
Laryngeal cancer
In 2011, there were 1137 new patients with laryngeal cancer in Thailand. 4 Carcinoma of larynx has the highest male-to-female ratio (10:1) among all Thai HN cancers, which is in line with earlier observations from Europe which reported that sex ratio in laryngeal cancer is the largest among all cancer sites. 34 It is well established that smokers have up to 10 times risk of laryngeal cancer. 6 The data from the National Statistical Office indicate that the overall smoking rate in Thailand dropped from 30% in year 1976 to 19 .9% in year 2013. 35 Indeed, according to the National Cancer Registry, the rate of laryngeal carcinoma in Thailand decreased from 4.0 in 1996 to 2.7 in 2011
(per 100 000 male population); however, this comparison should be treated with caution because of different methodologies used in different years. 5, 36 The vast majority of patients are over 50 years old, with the incidence peaked after age 70 years in both genders. 4 The most common histological variant is squamous cell carcinoma accounting for more than 95% of all laryngeal cancers. 37 Hospital-based cancer registries show that approximately two-thirds of tumors arise from glottic area. 11 Glottic cancer presents with the less advanced disease stage compared to the supraglottic location, which contributes to the higher 5-year survival (< 50% and >75% for the former and latter locations, respectively). 37 Laryngeal cancer has the highest 2-and 5-year overall survival compared to oral, oropharyngeal and hypopharyngeal cancers. 21 Worldwide ASR incidence of laryngeal carcinoma is 3.9 per 100 000 in males and 0.5 per 100 000 in females, which is higher than in Thailand. 12 At the same time, Thai rate of laryngeal cancer is comparable with the Southeast Asian estimates provided by GLOBOCAN (2.7 and 0.5 per 100 000 male and female population, respectively). Low incidence in Thai women can be attributed to the cultural predilection of not smoking and drinking. 35 
Hypopharyngeal cancer
Hypopharyngeal cancer in Thailand has an incidence similar to that of the oropharyngeal carcinoma (Table 1 ). There were 651 new cases diagnosed in 2011 in Thailand, with a male-to-female ratio 9:1. 4 Approximately 90% of patients were more than 50 years old, and around half of all the patients were older than 65 years old. 4 Hypopharyngeal cancer has the highest proportion of advanced stage disease at the time of diagnosis, which results in the worst survival rate among all HN cancers in Thailand. 15, 21 
Thyroid cancer
Thyroid cancer is the most common malignancy of the endocrine system. Anatomical position of the thyroid gland determines its placement under responsibility of HN multidisciplinary team. There were 2665 new cases of thyroid cancer recorded in 2011 in Thailand. 4 Thyroid carcinoma has a prominent gender disparity with a femaleto-male ratio exceeding 3:1. 38 In 2011, the mean annual incidence of thyroid malignancies in Thailand was 1.5 and 5.1 per 100 000 of male and female population, respectively (Table 1) . 4 and 2012. 39 Thyroid cancer in children and adolescents was extremely rare, accounting for 2.7% in both sexes. 4 Histological types of thyroid cancer are rarely recorded in regional cancer registries. The most consistent data were available from Eastern Thailand and showed predominance of papillary thyroid carcinoma (over 70%) among all thyroid cancers. Recent reports found that papillary carcinoma incidence increased and follicular carcinoma incidence decreased due to iodination policy, higher recognition of microcarcinomas and changes in histological classification. [40] [41] [42] In a line with other Asian countries, and at variance with Western practice, Thailand has very low rate of follicular variant of papillary thyroid carcinoma. 42 Molecular profile of thyroid cancer in Thailand appears similar to the neighboring countries; however, the evidence is limited. 43 More studies necessary to advocate and promote clinical molecular testing of thyroid nodules are anticipated. 44 Cancer prevalence and mortality are not reported in the major local source. 4 Estimates from GLOBOCAN show that thyroid cancer is the fourth most prevalent malignancy in the Thai female population. 12 It should be noted that this rate is based on the data from the limited number of Thai regional population-based registries contributing to GLOBOCAN database, and may not represent actual prevalence across the whole country. High prevalence of thyroid cancer is contributed by the relatively low mortality rate (0.6 per 100 000 by GLOBOCAN) compared to other malignancies. 12 The incidence of thyroid cancer is on steady rise worldwide. 45 The major reason behind this is a widespread use of high-resolution imaging able to detect small-sized low-risk cancers. The IARC experts claimed that enormous increase in thyroid cancer incidence in developed countries is subsequent to opportunistic and often unnecessary ultrasonography. 46 A similar trend of growing rate of thyroid microcarcinoma was recently reported from a single center in Bangkok, where incidence of subcentimeter cancers among thyroid surgical specimens doubled (from 15% to 32%) between 2005 and 2015. 41 GLOBOCAN 2012 data show that ASR per 100 000 population of thyroid cancer in
Thailand is not much different from the projected rates in Southeast Asia (4.5 -female, 1.8 -male), Asia (5 -female, 1.5 -male) and world (6.1 -female, 1.9 -male). 12 To conclude, according to the recent estimates, thyroid cancer is one of the most common malignancies in Thai women, occupying fourth rank by prevalence and seventh rank by incidence. There is slow but steady growth of thyroid cancer incidence in both sexes over the last two decades. The rate of thyroid cancer in Thailand is similar to average Asian and worldwide rates.
CONCLUSION
HN cancer is among the top five leading cancers in Thailand. Compared to the worldwide rates of HN malignancies, Thai population has lower incidence of laryngeal and thyroid cancers, and higher incidence of nasopharyngeal cancer. Despite important prognostic significance, the role of HPV infection in various HN cancers from Thailand has been rarely addressed to date. It should be noted that some GLOBOCAN estimates (e.g., incidence of oral, nasopharyngeal and thyroid cancer in male population) are discordant with the more precise data provided by the Thai National Cancer Registry. Moreover, some distinct sites such as larynx and hypopharynx are not represented in GLOBOCAN 2012. We believe that our summary presents baseline data on the current epidemiological situation and trends of HN cancer in Thailand and will offer insight to international and local communities involved in HN cancer research.
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